Logo image of IXHL

INCANNEX HEALTHCARE INC (IXHL) Stock Price, Quote, News and Overview

NASDAQ:IXHL - Nasdaq - US45333F1093 - Common Stock - Currency: USD

0.82  +0.21 (+34.43%)

After market: 0.801 -0.02 (-2.32%)

IXHL Quote, Performance and Key Statistics

INCANNEX HEALTHCARE INC

NASDAQ:IXHL (7/21/2025, 8:10:51 PM)

After market: 0.801 -0.02 (-2.32%)

0.82

+0.21 (+34.43%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High3.12
52 Week Low0.08
Market Cap24.13M
Shares29.43M
Float21.74M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)09-26 2025-09-26
IPO03-18 2022-03-18


IXHL short term performance overview.The bars show the price performance of IXHL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 100 200

IXHL long term performance overview.The bars show the price performance of IXHL in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of IXHL is 0.82 USD. In the past month the price increased by 274.26%. In the past year, price decreased by -62.15%.

INCANNEX HEALTHCARE INC / IXHL Daily stock chart

IXHL Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 55.39 722.35B
JNJ JOHNSON & JOHNSON 16.44 395.46B
NVO NOVO-NORDISK A/S-SPONS ADR 17.69 288.46B
NVS NOVARTIS AG-SPONSORED ADR 12.9 220.96B
AZN ASTRAZENECA PLC-SPONS ADR 15.8 213.06B
MRK MERCK & CO. INC. 10.18 199.15B
PFE PFIZER INC 7.56 137.93B
SNY SANOFI-ADR 10.56 116.71B
BMY BRISTOL-MYERS SQUIBB CO 6.36 95.02B
GSK GSK PLC-SPON ADR 8.15 73.23B
ZTS ZOETIS INC 24.48 65.61B
TAK TAKEDA PHARMACEUTIC-SP ADR 62.78 45.11B

About IXHL

Company Profile

IXHL logo image Incannex Healthcare, Inc. is a biotech company, which engages in developing cannabinoid and psychedelic compound medicines. The company is headquartered in New York City, New York and currently employs 9 full-time employees. The company went IPO on 2022-03-18. The firm is developing medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for the treatment of obstructive sleep apnea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, and pain, among other indications. The Company’s diversified portfolio includes 28 distinct research and development (R&D) programs, and six clinical trials underway. Its clinical projects include IHL-42X Obstructive Sleep Apnea, IHL-675A Inflammatory Lung Disease, IHL-675A Rheumatoid Arthritis, IHL-675A Inflammatory Bowel Disease, IHL-216A Concussion and TBI, PSI-GAD Psilocybin for anxiety, MedChew GB Post-herpatic Neuralgia and MedChew -1401 Pain and Spasticity in Multiple Sclerosis.

Company Info

INCANNEX HEALTHCARE INC

18 East 50th Street, 5th Floor

New York City NEW YORK US

Employees: 9

IXHL Company Website

IXHL Investor Relations

INCANNEX HEALTHCARE INC / IXHL FAQ

What is the stock price of INCANNEX HEALTHCARE INC today?

The current stock price of IXHL is 0.82 USD. The price increased by 34.43% in the last trading session.


What is the ticker symbol for INCANNEX HEALTHCARE INC stock?

The exchange symbol of INCANNEX HEALTHCARE INC is IXHL and it is listed on the Nasdaq exchange.


On which exchange is IXHL stock listed?

IXHL stock is listed on the Nasdaq exchange.


What is INCANNEX HEALTHCARE INC worth?

INCANNEX HEALTHCARE INC (IXHL) has a market capitalization of 24.13M USD. This makes IXHL a Nano Cap stock.


How many employees does INCANNEX HEALTHCARE INC have?

INCANNEX HEALTHCARE INC (IXHL) currently has 9 employees.


What are the support and resistance levels for INCANNEX HEALTHCARE INC (IXHL) stock?

INCANNEX HEALTHCARE INC (IXHL) has a resistance level at 0.86. Check the full technical report for a detailed analysis of IXHL support and resistance levels.


Is INCANNEX HEALTHCARE INC (IXHL) expected to grow?

The Revenue of INCANNEX HEALTHCARE INC (IXHL) is expected to grow by 2538.49% in the next year. Check the estimates tab for more information on the IXHL EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy INCANNEX HEALTHCARE INC (IXHL) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does INCANNEX HEALTHCARE INC (IXHL) stock pay dividends?

IXHL does not pay a dividend.


When does INCANNEX HEALTHCARE INC (IXHL) report earnings?

INCANNEX HEALTHCARE INC (IXHL) will report earnings on 2025-09-26.


What is the Price/Earnings (PE) ratio of INCANNEX HEALTHCARE INC (IXHL)?

INCANNEX HEALTHCARE INC (IXHL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.4).


What is the Short Interest ratio of INCANNEX HEALTHCARE INC (IXHL) stock?

The outstanding short interest for INCANNEX HEALTHCARE INC (IXHL) is 18.91% of its float. Check the ownership tab for more information on the IXHL short interest.


IXHL Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to IXHL. When comparing the yearly performance of all stocks, IXHL is a bad performer in the overall market: 83.48% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

IXHL Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to IXHL. IXHL may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IXHL Financial Highlights

Over the last trailing twelve months IXHL reported a non-GAAP Earnings per Share(EPS) of -1.4. The EPS increased by 64.01% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -214.35%
ROE -2466.94%
Debt/Equity 3.9
Chartmill High Growth Momentum
EPS Q2Q%-1.27%
Sales Q2Q%N/A
EPS 1Y (TTM)64.01%
Revenue 1Y (TTM)N/A

IXHL Ownership and Analysts

For the next year, analysts expect an EPS growth of -116.51% and a revenue growth 2538.49% for IXHL


Ownership
Inst Owners8.29%
Ins Owners13.03%
Short Float %18.91%
Short Ratio0.05
Analysts
AnalystsN/A
Price TargetN/A
EPS Next Y-116.51%
Revenue Next Year2538.49%